✦ LIBER ✦

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

✍ Scribed by Naoki Hayashi, Naoki Niikura, Hideko Yamauchi, Seigo Nakamura, Naoto T. Ueno

Book ID: 118796821
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 279 KB
Volume: 137
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2336-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone-receptor expression and activity

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

✍ Filippo Montemurro; Valentina Rossi; Maria Cossu Rocca; Rossella Martinello; Ele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Phase II Randomized Study of Trastuzumab

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

✍ Hurvitz, S. A.; Dirix, L.; Kocsis, J.; Bianchi, G. V.; Lu, J.; Vinholes, J.; Gua 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Value of serum human epidermal growth fa

Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing in breast cancer patients to maximize detection of her2/neu-positive patients and susceptability to Trastuzumab

✍ Fani Pakdel Azar; Homayy Shandiz Fatemeh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Prognostic value of positive human epide

Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer

✍ Lorenzo Livi; Icro Meattini; Calogero Saieva; Ciro Franzese; Vanessa Di Cataldo; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Economic evaluation of the 70-gene progn

Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan

✍ Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB